| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
1 company
Sandor Rosenberg last filed a Form 4 in February 2021, as Director at AIFF. Sandor Rosenberg's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 95,290 shares of AIFF. The AIFF filings lean toward selling, a net 1,750,000 shares.
Sandor Rosenberg has 2 Form 4 filings on record from January 2021 to February 2021, all as Director at Firefly Neuroscience (AIFF), 2021.
The 2 reported transactions were 2 open-market sales.
Counted by filing, the open-market trades come to no purchases and 2 sales worth about $1.0M.
The largest open-market sale was 1,200,000 shares of AIFF at an average $0.57 on January 29, 2021, about $686K.
Shares as reported in the last Form 4 for each company; the most recent is from February 2021. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.